Fatality owing to pulmonary hemorrhage following pamidronate disodium administration in a neonate with osteogenesis imperfecta type 2: A case report

We report the case of a patient with osteogenesis imperfecta (OI) who developed pulmonary hemorrhage 4 d after pamidronate disodium (PA) administration, despite a relatively stable respiratory status. Bisphosphonates are introduced to reduce osteoclast activity and are now widely used in patients wi...

Full description

Bibliographic Details

Published in:	Clinical Pediatric Endocrinology Vol. 33; no. 2; pp. 76 - 81
Main Authors:	Nagoshi, Rintaro, Amari, Shoichiro, Abiko, Yu, Wada, Yuka Sano, Ishiguro, Akira, Horikawa, Reiko, Ito, Yushi
Format:	Journal Article
Language:	English
Published:	Japan The Japanese Society for Pediatric Endocrinology 2024
Subjects:	bisphosphonates Case Report osteogenesis imperfecta pamidronate disodium pulmonary hemorrhage pulmonary hemorrhage bisphosphonates osteogenesis imperfecta pamidronate disodium
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!